Polymyalgia rheumatica epidemiology and demographics
|
Polymyalgia Rheumatica Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polymyalgia rheumatica epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Polymyalgia rheumatica epidemiology and demographics |
|
Polymyalgia rheumatica epidemiology and demographics in the news |
|
Blogs on Polymyalgia rheumatica epidemiology and demographics |
|
Risk calculators and risk factors for Polymyalgia rheumatica epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Polymyalgia rheumatica (PMR) affects mostly subjects who are more than 50 years of age.[1] The prevalence of PMR is highest among subjects from Scandanavian countries and those from northern European origin.[2]
Epidemiology and Demographics
Incidence
Age
- The incidence of polymyalgia rheumatica increases with age.
Gender
- Females are more affected with polymyalgia rheumatica than men. [1]
Race
- PMR affects more than 700,000 subjects in the United States.[3]
- There is a geographical association with the prevalence of PMR; in fact, PMR occurs more among subjects from Scandanavian countries and those from northern European origin.[2][4]
- PMR mostly affects people who are older than 50 years of age.[1]
- The mean age for the occurrence of PMR is 74 years.
- There is an association between PMR and giant cell arteritis. While 40 to 60% of patients with giant cell arteritis have PMR, 16 to 21% of patients with PMR develop giant cell arteritis.[5][6][7]
References
- ↑ 1.0 1.1 1.2 Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE (2002). "Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA". J Rheumatol. 29 (8): 1694–7. PMID 12180732.
- ↑ 2.0 2.1 Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N (2009). "Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data". Clin Exp Rheumatol. 27 (5): 830–3. PMID 19917168.
- ↑ Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA; et al. (2008). "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II". Arthritis Rheum. 58 (1): 26–35. doi:10.1002/art.23176. PMC 3266664. PMID 18163497.
- ↑ Cimmino MA, Zaccaria A (2000). "Epidemiology of polymyalgia rheumatica". Clin Exp Rheumatol. 18 (4 Suppl 20): S9–11. PMID 10948749.
- ↑ Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG (1995). "The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern". Ann Intern Med. 123 (3): 192–4. PMID 7598301.
- ↑ Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG (1995). "Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991". Arthritis Rheum. 38 (3): 369–73. PMID 7880191.
- ↑ Franzén P, Sutinen S, von Knorring J (1992). "Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988". J Rheumatol. 19 (2): 273–6. PMID 1629827.